Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
Anna Randi, Professor of Cardiovascular Medicine at Imperial College London, shared on LinkedIn:
”Delighted to share the latest episode of the VWF and angiogenesis story from my lab Vascular Section – NHLI, Imperial College London.
Finally, experimental evidence that Angiopoietin2 inhibition could benefit VWD patients with GI bleeding and angiodysplasia.
This was true teamwork: thank you to the excellent members of my team at Imperial, particularly Adela Constantinescu-Bercu and Koval Smith, PhD, and a fantastic network of collaborators (Marco Rasponi, Petrova Lab – Vascular and tumor biology, Suthesh Sivapalaratnam).
A special thanks to the VWD patients who generously donated their blood to advance research.
Thank you to the Medical Research Council, the British Heart Foundation, the Rosetrees trust and the NIHR (National Institute for Health and Care Research) Imperial BRC.
Thank you to Barbara Bianchi Bonomi for the recent generous award, highlighting the relevance of this research to patients with VWD.
A hugely satisfying project with real life impact.”
Read the full article here.
Article: Von Willebrand Factor Deficiency Impairs Angiogenesis via Angiopoietin-2: Relevance for Gut Angiodysplasia
Authors: Adela Constantinescu-Bercu, Koval E Smith, Shuo Yi Wong, Mattia Ballerini, Alessia Nastro, Benjamin G Wiggins, Daniela Pirri, Yucheng Li, Juun Anora Maria Evers, Olga Tsiamita, Matthew Dibble, Charis Pericleous, Koralia E Paschalaki, Graeme M Birdsey, Jeremiah Bernier-Latmani, Tatiana V Petrova, Mike A Laffan, Suthesh Sivapalaratnam, Marco Rasponi, Anna M. Randi
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care